- In Memoriam
- About
- Apply
- People
- Education
- Events
- Articles
-
News
News Fatty Liver Foundation Launches Groundbreaking Patient Advocacy Fellowship Honoring Dr. Stephen A. Harrison Fatty Liver Foundation Announces Inaugural Cohort of the Dr. Stephen A. Harrison Patient Advocacy Fellowship Fatty Liver Foundation to Introduce Dr. Stephen A. Harrison Patient Advocacy Fellowship at Liver Forum 19 in Paris, France The Dr. Stephen A. Harrison Patient Advocacy Fellowship Program on Surfing the MASH Tsunami Harrison Fellows Convene at AASLD’s The Liver Meeting® 2025 Harrison Fellows Engage at 10th Annual MASH-TAG Conference
- FAQ
- Contact
Dr. Harrison's Quotes
There are a few notable quotes attributed to Dr. Stephen Harrison that highlight his contributions and impact in the field of hepatology and liver disease research.
One insightful quote emphasizes the essence of patient care:
“We cannot lose sight of the patients behind the science. Their stories and struggles drive our research and innovation.”
This statement reflects his deep commitment to ensuring that clinical research has tangible benefits for patients suffering from liver diseases, particularly NASH (non-alcoholic steatohepatitis) and other liver-related conditions.
Another quote that showcases his philosophy in medicine is:
“Innovation does not happen in isolation. It requires collaboration, dedication, and a persistent focus on the needs of the community we serve.”
This indicates his belief in teamwork and the importance of interdisciplinary approaches in advancing medical science.
Furthermore, Dr. Harrison was also known for his motivational insights, including a memorable phrase:
“The only failure in medicine is the failure to take action when we know we should.”
This reflects his proactive approach in medical practice and the need for timely intervention in patient care and research.
These quotes not only depict Dr. Harrison as a distinguished physician but also highlight his unwavering dedication to enhancing the lives of patients through research and innovation in hepatology. His legacy is carried on by those he has inspired within the medical community and beyond.
Dr. Harrison was a respected figure in the field of liver disease research, with many significant contributions and insights during his career. Notably, he emphasized the importance of advancing understanding and treatment options for liver diseases, particularly Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
In his interactions, he often highlighted the critical need for effective treatments in this area, emphasizing:
"The ongoing development of medications for NASH reflects not only the urgency of the disease but also the collective effort of scientists and clinical researchers worldwide."
This underscores his belief in collaborative efforts to tackle liver diseases.
Moreover, during his tenure as a consultant and leader in clinical research, Dr. Harrison emphasized that treating liver disease requires a robust pipeline of new therapies. He stated:
"Our commitment to finding innovative therapies for liver diseases must remain unwavering, as the implications of these conditions on public health are profound."
This further illustrates his dedication to improving therapeutic options for patients.
Dr. Stephen Harrison was a prominent figure in the field of hepatology, and his passing has prompted many to reflect on his significant contributions. Harrison's impact was so profound that he has been likened to William Shakespeare in the field of hepatology, highlighting the depth and breadth of his influence on liver disease research and patient care .
Throughout his career, Harrison demonstrated a visionary approach and collaborative spirit, which were pivotal in advancing hepatology. His work led to significant research advancements, particularly at Summit Clinical Research, where he contributed to the understanding of fatty liver disease and various liver disorders. His commitment to informing and improving patient care was evident through his active participation in clinical research and continued education.
Moreover, his legacy is also marked by his dedication to the community of liver disease patients. The American Liver Foundation recognized Harrison for his remarkable impact on both the field of hepatology and the lives of those suffering from liver diseases. His leadership and passion for hepatology were instrumental in raising awareness and fostering support for patients.
Many colleagues and friends have expressed their condolences and admiration for his work, emphasizing the considerable void his absence has created in the medical community. Dr. Harrison's contributions will undoubtedly continue to inspire future generations of hepatologists and researchers in pursuit of innovations in liver health.